ClinicalTrials.gov
public full text
Public Domain
A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement
The current study is proposed to evaluate whether there is any clinically meaningful effect of hepatic impairment on the plasma Pharmacokinetic (PK) of HDM1002
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)#849389
- A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects#830262
- A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment#850711
- Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults#911681
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults#141180
Record · ID 1033378
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive